Skip to content

BioNTech SE

BNTX

CIK 0001776985

← back to feed
Revenue (TTM)
—
FY Mar 2026
Net Income (TTM)
−€1.14B
−70.8% YoY FY Mar 2026
EPS Diluted (TTM)
−€4.70
−69.7% YoY FY Mar 2026
Gross Margin
—
FY Mar 2026
Operating Margin
—
FY Mar 2026
Net Margin
—
FY Mar 2026
Free Cash Flow (TTM)
—
FY Mar 2026
Cash
€7.68B
FY Mar 2026
Total Debt
—
FY Mar 2026
Shares Outstanding
252.88M sh
FY Mar 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings